![Cystic Fibrosis News Today](https://cysticfibrosisnewstoday.com/wp-content/uploads/2015/10/cysticFibrosisNewsToday_black-290.png)
Suscribirse a:
Enviar comentarios (Atom)
Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
Vertex Pharmaceuticals plans to conclude the enrollment of patients in its Phase 3 programs involving its triple combo therapies to treat cystic fibrosis (CF) in the second half of 2018, the company recently announced in a corporate update. This is earlier than expected for the four Phase 3 trials, which are testing triple combinations of VX-661 (tezacaftor) and […] The post Vertex Anticipates Completing Enrollment of Phase 3 Trials Testing Triple Combo Therapies appeared first on Cystic Fibrosis News Today. | ||
|
No hay comentarios:
Publicar un comentario